Moreover, the expression levels of these cell adhesion molecules were significantly associated with improved patient survival, further supporting the potential protective role of ALDH1A2 in prostate cancer progression through these cell adhesion molecules. The gene discussed is ALDH1A2; the disease is prostate carcinoma.